Barbara Christine Potts

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Nereus Pharmaceuticals, Inc., Other. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara Christine Potts. Retrieved from https://idiyas.com/inventor/barbara-christine-potts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 41.7

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 101(Granted Patents)

Company Filing History:

11 out of 36

Nereus Pharmaceuticals, Inc.

patents

1 out of 834,513

Other

patents

Years Active: 2007-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8389564 - Proteasome inhibitors (2013-03-05),

2. 8227503 - Proteasome inhibitors (2012-07-24),

3. 8067616 - Total synthesis of salinosporamide A and analogs thereof (2011-11-29),

4. 7910616 - Proteasome inhibitors (2011-03-22),

5. 7842814 - Total synthesis of salinosporamide A and analogs thereof (2010-11-30),

6. 7824698 - Lyophilized formulations of Salinosporamide A (2010-11-02),

7. 7579371 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof (2009-08-25),

8. 7544814 - [3.2.0] Heterocyclic compounds and methods of using the same (2009-06-09),

9. 7375129 - Bis-indole pyrroles useful as antimicrobials agents (2008-05-20),

10. 7276530 - [3.2.0] Heterocyclic compounds and methods of using the same (2007-10-02),

11. 7250438 - Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams (2007-07-31),

12. 7166634 - Bis-indole pyrroles useful as antimicrobials agents (2007-01-23),

Title: The Innovator: Barbara Christine Potts

Introduction: Barbara Christine Potts is a notable inventor based in Escondido, California. With a remarkable portfolio of 12 patents, she has made significant contributions in the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various medical conditions.

Latest Patents: Among her latest patents are groundbreaking formularies for proteasome inhibitors. These patents disclose compounds of Formula (I) which incorporate a sulfonate ester, ester, or ether group. These compounds are valuable in pharmaceutical compositions and hold potential for treating and ameliorating diseases such as cancer, microbial diseases, and inflammation.

Career Highlights: Barbara has built her career around pioneering research and innovative therapeutic solutions. Her expertise and dedication to her work have led her to achieve acknowledgment within the scientific community for her transformative inventions.

Collaborations: Throughout her career, Barbara has collaborated with esteemed professionals in the industry, including Katherine A. McArthur and Rama Manam. These collaborative efforts have played a crucial role in advancing research and developing effective treatments.

Conclusion: Barbara Christine Potts exemplifies the spirit of innovation in the pharmaceutical field. With her groundbreaking patents and collaborative approach, she continues to make strides in the development of treatments that address critical health issues, inspiring future generations of inventors and researchers.

Profile summary based on public USPTO records.